by Robin Dvorak | Jan 21, 2026
enGene is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs.
by Robin Dvorak | Jun 30, 2025
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The company is developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of...
by Robin Dvorak | Jun 12, 2025
Genetix Biotherapeutics Inc. is a privately held, commercial-stage biotechnology company dedicated to delivering genetic therapies for patients with severe rare diseases. Backed by more than 30 years of pioneering genetic therapy innovation, the company has...
